NCT00375622View on ClinicalTrials.gov

Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

June 30, 2006

Conditions

Hereditary Hemorrhagic Telangiectasia

Interventions

DRUG

Tamoxifen

Trial Locations (1)

49100

Rabin Medical Center, Petah Tikva

All Listed Sponsors

lead

Rabin Medical Center

OTHER

NCT00375622 - Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial | Biotech Hunter | Biotech Hunter